Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aziya Immunopreparat is a pharmaceutical manufacturing company located in Tashkent, Uzbekistan, that focuses on the production of immunobiological drugs and vaccines. The company plays a critical role in the regional healthcare infrastructure by providing essential products such as anti-rabies vaccines and tetanus toxoids. Its manufacturing capabilities include the production of sterile injectable solutions and various other pharmaceutical dosage forms. Aziya Immunopreparat operates under the regulatory framework of the Uzbekistan Ministry of Health and contributes significantly to the country's self-sufficiency in vital medicines. The company is recognized as a key supplier for state procurement programs aimed at controlling infectious diseases within the Republic of Uzbekistan. In addition to vaccines, the company produces a range of therapeutic serums and diagnostic reagents used in clinical laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AZIYA IMMUNOPREPARAT.